Patent · US Active

Method of conferring a protective immune response to norovirus

US10130696B2 · kind B2 · utility

7Cited by
26References
27Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 18, 2008
Grant dateNov 20, 2018
Priority date
Expiry dateDec 2, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2770/16034
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to vaccine compositions comprising Norovirus antigens and adjuvants, in particular, mixtures of monovalent VLPs and mixtures of multivalent VLPs, and to methods of conferring protective immunity to Norovirus infections in a human subject.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.